Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study
Mary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
JAMA Network Open
|
October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life
Sagar A Patel, Dattatraya Patil, Joseph Smith, et al.
JAMA Oncology
|
April 18, 2024
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Jeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, et al.
Nature
|
December 13, 2019
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Caroline S Jansen, Nataliya Prokhnevska, Viraj A Master, et al.
JAMA Oncology
|
May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer
Martin G Sanda, Ziding Feng, David H Howard, et al.
JCO Precision Oncology
|
February 26, 2019
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
Eve O'Reilly, Alexandra V Tuzova, Anna L Walsh, et al.
Science Translational Medicine
|
August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
Scott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
The Journal of Urology
|
September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort
Lisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
The Journal of Urology
|
April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI
Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
HGG Advances
|
January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment
Yu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study
Mary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
JAMA Network Open
|
October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life
Sagar A Patel, Dattatraya Patil, Joseph Smith, et al.
JAMA Oncology
|
April 18, 2024
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Jeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, et al.
Nature
|
December 13, 2019
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Caroline S Jansen, Nataliya Prokhnevska, Viraj A Master, et al.
JAMA Oncology
|
May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer
Martin G Sanda, Ziding Feng, David H Howard, et al.
JCO Precision Oncology
|
February 26, 2019
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
Eve O'Reilly, Alexandra V Tuzova, Anna L Walsh, et al.
Science Translational Medicine
|
August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
Scott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
The Journal of Urology
|
September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort
Lisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
The Journal of Urology
|
April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI
Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
HGG Advances
|
January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment
Yu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Page
of 18